The vast majority of our patients choose this procedure to start their rejuvenation journey
doi:10.1007/s00405-020-05925-9
Peripheral effects Via the AMY2 and AMY3 receptors Cagrilintide acts peripherally: Slowing of gastric emptying , stronger than with GLP-1 Suppression of postprandial glucagon , helps control postprandial glycemic spikes Modulation of bone remodeling (via AMY3), a neutral effect, but clinically monitored Synergy with GLP-1 (the mechanistic basis of CagriSema) The main innovation is the complementarity with the GLP-1 pathway : GLP-1 suppresses appetite via the arcuate nucleus of the hypothalamus (POMC neurons, AgRP/NPY inhibition) Amylin suppresses appetite via the area postrema (CGRP-like neurons) Two independent centers, two independent mechanisms
Green Tea Leaf Extract (Camellia sinensis) (Standardized to 50% EGCG, 98% Polyphenols), Organic Matcha Green Tea Leaf, Organic Peppermint Leaf, Organic Lemon Peel
A compound that supports all injured structures together could meaningfully compress recovery timelines
A final consideration relates to the potential risk for GLP-1RA therapy to contribute to progression of pancreatic cystic lesions